SCHEMBL30584385

SCHEMBL30584385

Cc1cc([C@@H](C)N)c2oc(-c3ccccc3)c(C)c(=O)c2c1.[N]

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.45
▸ CYP3A4 P08684 2/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ MAPT P10636 4/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ LMNA P02545 4/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ CHRM2 P08172 1/20 0.39
▸ HTR1A P08908 1/20 0.39
▸ ADRA2A P08913 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CHRM1 P11229 1/20 0.39
▸ ACHE P22303 1/20 0.39
▸ SLC6A2 P23975 1/20 0.39
▸ PDE4A P27815 1/20 0.39
▸ ADRA1A P35348 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24913011 0.99 ALDH1A1 (0.46) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL26880870 0.99 ALDH1A1 (0.46) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL26662647 0.89 ALDH1A1 (0.44) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL26662643 0.89 ALDH1A1 (0.44) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL30584420 0.89 ALDH1A1 (0.44) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL26662629 0.87 ALDH1A1 (0.47) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL31316385 0.87 ALDH1A1 (0.47) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL24912996 0.87 ALDH1A1 (0.47) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL31035409 0.86 ALDH1A1 (0.49) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL31035111 0.86 ALDH1A1 (0.46) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4514784-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE Petra Pharma Corporation (US) 2025-03-05 — — EP disclosed
WO-2023212693-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE PETRA PHARMA CORPORATION (US) 2023-11-02 — — WO disclosed
Send feedback